编辑丨王多鱼 排版丨水成文 近十年来，中国科学家在 细胞出版社 （Cell Press） 旗下期刊上的论文数量实现了跨越式增长，研究主题从单一学科拓展到交叉前沿，合作网络从国内延伸至全 球，展示了中国科研在原创性、系统性与开放性上的全面提升。无论是在生命科学、物质科学，还是在能源、医学与人工智能等交叉领域，中国科学家的声音都 越来越清晰、越来越有分量。 2024 年，中国科学家的研究产出数量持续提升，以中国机构为第一完成单位、发表在 细胞出版社 （Cell Press） 旗下研究型期刊上的研究论文数量继续快速增 长， 总发文量达到 2446 篇，较上一年增加了 17.6%，是 2020 年发表量的近 4 倍 。 近日， 细胞出版社 （Cell Press） 评选出了" 细胞出版社 2024 中国年度论文 "， 生命科学领域、物质科学领域、医学领域、交叉学科领域和可持续发展五个领 域，每个领域 10 篇，共计 50 篇，全部入选论文详见： 细胞出版社2024中国年度论文奖重磅公布：十年见证中国科研前进之路！ 本文将介绍入选 " 细胞出版社 2024 中国年度论文 "的 医学 领域 10 篇论文，排名不分先后。生 ...

中证报中证网讯(记者傅苏颖)日前，在德国杜塞尔多夫国际医院及医疗设备展览会(MEDICA2025)上， 怀柔科学城首次参展，累计接待超过1500家机构咨询，德国西门子医疗、瑞士联邦出口与投资促进机 构、德中经济联合会、西班牙卡斯蒂利亚-莱昂自治区政府等30余家机构与企业代表明确表达了近期赴 怀柔科学城实地考察的意向，并期待进一步合作。 怀柔科学城展区分为概况、科研成果展示与国际交流三部分，全景展示了其围绕物质、空间、生命、地 球系统、信息与智能五大科学方向布局的37个科学设施平台，重点展示了医疗影像等生命科学领域的大 科学设施平台与前沿成果，生动呈现"聚人气、聚科研气"的良好态势。 同时，西班牙外贸与投资促进局、德国联邦经济与气候保护部、瑞士出口与投资促进机构、慕尼黑工业 大学等机构主动到访怀柔科学城展位，详细了解科学城建设进展后，对大科学装置集群的开放共享机制 和科研生态氛围给予了高度评价。高校院所等机构代表进一步表达了在人才交流与联合研究等方面的合 作意愿。部分国内生命健康领域参展企业也来到展位，探讨入驻落地及技术合作的可能性。 据悉，怀柔科学城已进入运行为主的新阶段，4个大科学装置通过国家验收并运行，1 ...

Core Insights - The Chinese Academy of Sciences and the Chinese Academy of Engineering announced the results of the 2025 academician elections, electing 73 academicians from the former and 71 from the latter, highlighting significant contributions from Suzhou experts [1][2] Group 1: New Academicians - Four experts from Suzhou were elected as academicians, including Zhu Lan and Qian Linfang for the Chinese Academy of Sciences, and Wang Jianwei and Sun Baode for the Chinese Academy of Engineering [1] - Zhu Lan, a prominent figure in obstetrics and gynecology, has made significant contributions to clinical, teaching, and research work, establishing a strong international influence [1] - Qian Linfang, an expert in artillery weapon systems, has played a crucial role in the development of China's artillery technology and modernization of national defense equipment [1] Group 2: Contributions of Suzhou Academicians - Wang Jianwei, director of the Chinese Center for Disease Control and Prevention, has led over 10 national-level major research projects focusing on the pathogenic mechanisms and prevention of respiratory viral infections [2] - Sun Baode, a professor at Shanghai Jiao Tong University, has conducted extensive research in metal materials and solidification technology, leading over 50 major projects with applications in aerospace and high-voltage transmission [2] Group 3: Suzhou's Commitment to Science and Talent - Suzhou is recognized as a "city of academicians," actively promoting initiatives to attract full-time academicians, including the establishment of "Suzhou Scientist Day" and various funding measures [3] - The city has implemented policies offering up to 30 million yuan in project funding and 3 million yuan in personal rewards to attract high-level scientific talent [3] - Suzhou aims to provide the highest recognition and support for talents, reinforcing its commitment to becoming a hub for scientific innovation and development [3]

Core Viewpoint - The recent election results for the Chinese Academy of Sciences and the Chinese Academy of Engineering highlight a significant focus on cancer research, particularly in liver and gastrointestinal cancers, with notable advancements in prevention and early diagnosis [3][4]. Group 1: New Academicians - A total of 73 new academicians were elected to the Chinese Academy of Sciences, and 71 to the Chinese Academy of Engineering [3]. - Among the newly elected academicians, significant contributions come from experts in clinical medicine, particularly in cancer research [3]. Group 2: Focus on Liver Cancer - The field of liver cancer remains a critical area of research, with approximately 900,000 new cases globally each year, and China accounting for nearly half of these cases [3]. - A major report published in The Lancet by academicians Zhou Jian and Fan Jia indicates that at least 60% of liver cancer cases are preventable through risk factor reduction [4]. Group 3: Innovations in Diagnosis and Treatment - Zhou Jian and Fan Jia have developed a miRNA-based early diagnosis model for liver cancer, which has been successfully transformed into a clinical application, significantly improving early detection rates compared to traditional markers [5]. - The overall survival rate for treated patients has reached an international leading level due to innovative personalized treatment strategies [5]. Group 4: Gastrointestinal Cancer Research - Gastrointestinal cancer also has a high incidence rate in China, with significant contributions from academician Fang Jingyuan in early diagnosis, prevention, and comprehensive treatment strategies [5].

Core Insights - Ant Group and West China Hospital of Sichuan University signed a strategic cooperation agreement during the World Internet Conference in Wuzhen on November 8 [1] - The collaboration aims to leverage West China Hospital's clinical experience and research foundation alongside Ant Group's technological capabilities and ecosystem resources [1] - The focus will be on chronic diseases, particularly respiratory system diseases, to advance scientific research, service system development, and the integration of "AI + healthcare" [1] - The partnership aims to enhance the accessibility of quality medical resources and empower grassroots healthcare service capabilities [1]

Core Insights - The "People's Good Doctor · Jinshan Camellia Plan" aims to enhance academic exchange in the field of urological tumors, emphasizing the importance of both clinical practice and research for young and middle-aged doctors [1][2] - The initiative has been instrumental in promoting cross-regional sharing of research outcomes and clinical experiences, thereby improving the professional capabilities of young urologists [1] Group 1 - Young and middle-aged doctors should adhere to the principle of balancing clinical practice and research to enhance their core competencies in complex surgeries and critical care [1] - Research is deemed essential for overcoming clinical challenges and advancing overall medical progress [1] - The plan serves as a high-quality platform for academic exchange, facilitating the sharing of research and clinical experiences among urologists [1] Group 2 - The "People's Good Doctor · Jinshan Camellia Plan" was initiated in 2020 to promote the clinical translation of research outcomes and support cancer prevention efforts [2] - The program highlights outstanding contributions from young experts in nine major cancer treatment areas, including urological tumors [2]

Core Insights - The report titled "China Neurological Disease Report 2024" was jointly released by multiple medical institutions under the guidance of the National Health Commission, covering 15 types of neurological diseases including cerebrovascular diseases and Parkinson's disease [1] - Breakthroughs have been achieved in brain-machine interface (BMI) research for treatment-resistant epilepsy, Parkinson's disease, amyotrophic lateral sclerosis, and spinal cord injuries [1] - The first global clinical trial of an epidural brain-machine interface began in October 2023, in collaboration with Tsinghua University, aiming to validate the effectiveness and safety of invasive BMI treatment options [1] Group 1 - The National Center for Neurological Diseases has completed the implantation of BMIs in 32 patients with quadriplegia, capturing brain signals to simulate normal physiological conduction [3] - The BMI technology shows significant potential in the medical health field, providing new treatment hopes and rehabilitation pathways for a large patient population suffering from neurological diseases [5] - The use of non-invasive BMIs is expected to explore human brain activity and dynamic changes, contributing to understanding aging mechanisms and enhancing elderly functionality [7]

Core Points - The U.S. federal government shutdown has lasted for 16 days, marking the longest shutdown in nearly seven years, exposing deep political polarization and leading to a systemic crisis affecting various sectors of the economy [1][15] - The shutdown has resulted in significant economic losses, estimated at $1 billion per day, totaling $16 billion over the 16 days, with severe impacts on tourism, small businesses, and federal spending [5][15] Economic Impact - The shutdown has caused daily economic losses of approximately $1 billion, with tourism alone losing $100 million per day and 42,000 small businesses facing financing delays due to loan guarantees being stalled [5] - Federal spending delays amount to $12 billion, affecting essential programs such as agricultural subsidies and housing assistance [5] Agricultural Sector - The agricultural industry is facing severe disruptions, with farmers unable to access loans, leading to potential business closures; for instance, 30% of farms in Arkansas are at risk of closure due to halted disaster aid applications [5][9] Financial Markets - Financial markets are experiencing volatility due to delayed economic data releases, which have affected Federal Reserve policy expectations, with interest rate cut probabilities fluctuating significantly [7] - The uncertainty surrounding the shutdown has led to increased spreads in emerging market dollar bonds, raising financing costs for vulnerable economies like Argentina and Turkey [11] Public Services - The shutdown has led to significant disruptions in public services, including delays in cancer drug approvals and clinical trials, as well as increased flight delays due to staffing shortages in the aviation sector [9] - The Federal Aviation Administration has seen 11,000 employees on unpaid leave, resulting in a 23% increase in flight delays [9] Political Context - The budget standoff is tied to ideological battles between the two parties, with Republicans pushing for cuts to social programs and increased defense spending, while Democrats advocate for tax increases on the wealthy to maintain social services [3] - The political deadlock has raised concerns about the potential for future shutdowns, with historical data indicating that shutdowns have occurred approximately every two years since 1976 [13]

Core Points - The 2024 Anhui Provincial Science and Technology Awards have concluded, with a total of 64 first prizes, 84 second prizes, and 142 third prizes recommended for the provincial science and technology awards [1]. Group 1: Natural Science Awards - The first prize projects include research on dual-phase flow phase change and mathematical theories related to the Navier-Stokes equations, brain cognitive function analysis based on cross-modal neuroimaging, and mechanisms of intestinal immune perception and disease [3]. - Notable institutions involved in first prize projects include Anhui Normal University and the University of Science and Technology of China [3]. Group 2: Technical Invention Awards - Key projects awarded first prizes include diamond quantum current sensors and technologies for new distribution systems with electrical and communication coupling [7]. - The projects involve collaboration between institutions such as Hefei University of Technology and State Grid Anhui Electric Power Company [7]. Group 3: Scientific Progress Awards - First prize projects focus on autonomous systems, multi-element metal/ceramic functional coatings, and ecological coordination reinforcement technologies [10]. - Institutions like Anhui University and Anhui University of Science and Technology are prominently featured in these projects [10]. Group 4: Agricultural Technology Awards - First prize projects include key technologies for managing herbicide resistance in major crops and the creation of high-quality disease-resistant rice varieties [11]. - Collaborating entities include Anhui Agricultural University and various agricultural technology companies [11]. Group 5: Environmental and Energy Technologies - Projects awarded for their contributions to environmental technology include those focused on wastewater treatment and the development of lightweight, high-quality materials for energy applications [8][12]. - Institutions involved in these projects include the University of Science and Technology of China and Hefei University of Technology [8][12].

Core Points - The State Council has appointed Zheng Zhe as the Deputy Director of the National Health Commission, replacing Cao Xuetao, who has an academic background and previously served as the President of Nankai University [1][3] - Zheng Zhe is known for his expertise in cardiovascular surgery, focusing on clinical, research, and educational work related to heart diseases [1][2] Group 1 - Zheng Zhe's research group primarily focuses on the mechanisms and treatment methods for common cardiovascular diseases, including ischemic heart disease and arrhythmias, with several new devices for atrial fibrillation treatment being developed [2] - The team has established the "China Cardiovascular Surgery Registry Study (CCSR)" to enhance the quality of cardiovascular surgery across collaborating hospitals [2] - Zheng Zhe has led multiple national and provincial research projects, publishing results in prestigious journals and receiving several national science and technology awards [2] Group 2 - Zheng Zhe, born in 1971, is the first "post-70s" leader in the National Health Commission, while the outgoing Cao Xuetao, born in 1964, has a long-standing career in immunology and was elected as an academician of the Chinese Academy of Engineering in 2005 [3] - During Cao Xuetao's tenure as President of Nankai University, he implemented various initiatives to improve the university's academic performance and environment [3]